GLOBAL FOOTPRINT
We have a presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We aim to deliver highly innovative medicines and transformative care for more people globally.
14
%
18
%
~¥3.3T
~$30B
48
%
20
%
*Takeda and Shire combined, historical pro-forma based on 2017 data